The Next Look At Amgen's Obesity Drug Is Coming. Here's What Investors Are Watching.
In This Article:
Later this month, the Street will have a fresh opportunity to gauge the potential for Amgen's experimental weight-loss drug, MariTide.
Terms and Privacy Policy